The Vall d´Hebron Institute of Oncology (VHIO) Seeks a “Junior Group Leader”
Reference: Ref. 46-2023
Application deadline: Applications will be considered until May 31st, 2023.
Number of vacancies: 1
We Seek:
Vall d´Hebron Institute of Oncology (VHIO) is a cancer research center associated with Vall d’Hebron University Hospital that combines translational and clinical research to address the most unmet needs in cancer research and patient care.
The VHIO opens a Junior Group Leader position and invites applications from outstanding young investigators interested in launching an independent research laboratory in translational cancer research oriented to understanding mechanisms of disease and generating insights for clinical translation.
Applicants should have a PhD or MD/PhD degree, grounded postdoctoral research experience and strong leadership skills, as well as demonstrate a strong track-record of publications during their postdoc and capacity to attract competitive funding.
What do we offer:
- Being part of a center that is constantly developing, highly competitive, seeking excellence in research and collaborating with leading teams.
- The successful candidate will be provided with laboratory space, a competitive start-up package, and access to state-of-the-art core units and facilities to develop their research proposal.
- Working in a highly collaborative and interdisciplinary environment, in close interaction with clinical researchers within the context of our transversal taskforces.
- We offer and promote a diverse and inclusive environment and welcome all people equally, regardless of age, disability, gender, nationality, race, religion, or sexual orientation.
Application:
Applicants should include a full CV, letter of intent, brief (3-page max) research proposal, and the names of at least two references to selecciorrhh@vhio.net, including the reference “Ref. 46-2023” in the subject line of your email.
Expressions of interest will be immediately reviewed by the VHIO’s Internal Scientific Committee.
About VHIO:
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO’s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d’Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d’Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO’s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.
For more information, including a description of the research programs, please visit: https://www.vhio.net
Vall d’Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies.
On 10th April 2018 VHIO was awarded the “HR Excellence in Research” logo. Our Institute was consequently granted permission to use the HR Excellence in Research Award logo as demonstration of its stimulating and favourable work environment in line with the Charter & Code.
